Volda, Norway

Jan Wadstein

This inventor holds 1 USPTO granted patent. Top assignee: Aker Biomarine Asa. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Wadstein. Retrieved from https://idiyas.com/inventor/jan-wadstein-yefm1kw6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan Wadstein: Innovator in Hypertension Treatment

Introduction: Jan Wadstein is an inventor based in Volda, Norway, recognized for his contributions to medical innovation. His work primarily focuses on methods for treating hypertension and reducing serum lipase activity through dietary supplementation.

Latest Patents: Jan has been awarded one patent for his innovative approach titled, "Method of treating hypertension and reducing serum lipase activity." This invention relates specifically to using conjugated linoleic acid as a dietary supplement. The method involves administering a safe and effective amount of conjugated linoleic acid to individuals, which can be delivered in pill form or incorporated into prepared food products.

Career Highlights: Jan Wadstein is currently associated with Aker Biomarine ASA, a company esteemed for its commitment to sustainable marine ingredients. His expertise in medical innovation is exemplified through his patent, which addresses critical health issues in modern society.

Collaborations: Throughout his career, Jan has collaborated with notable professionals, including his coworker Jan Remmereit. Together, they contribute to advancing research in health and nutrition.

Conclusion: Jan Wadstein stands out as an inventive figure in the realm of health solutions, specifically in the management of hypertension through innovative dietary practices. His patent not only showcases his creativity and understanding of health but also highlights the importance of collaboration in the field of medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…